StockWatch
·
Q2 FY-2027 RESULTS · TURTLEMINT

Turtlemint Q2 FY27: consolidated loss narrows to ₹25.8 Cr, revenue up 35% YoY to ₹342 Cr

PAT +67.08% YoY · revenue +35.34% · margins expanding · inline vs street

Q2 FY27 resultsTURTLEMINTTurtlemint Fintech Solutions Ltd12 Nov 2026 · 3 min read
Revenue

₹342.19 Cr

+35.34% YoY

PAT (consolidated)

₹-25.83 Cr

+67.08% YoY

Net margin

-7.35%

EPS

₹-1

Turtlemint Fintech's consolidated (primary basis) revenue rose 35.3% YoY and 16.0% QoQ to ₹342.19 Cr, while the consolidated net loss narrowed to ₹25.83 Cr from ₹37.78 Cr in Q1 FY27 (-31.6% QoQ). Against Q2 FY26's reported ₹78.45 Cr loss the improvement looks like 67%, but that prior quarter carried a ₹33.98 Cr one-off financial-instruments-related exceptional expense tied to a CCPS conversion-ratio adjustment; stripping that out, the adjusted prior-year loss was ₹44.47 Cr, so the real underlying YoY loss-narrowing is closer to 42%. This quarter carried no exceptional items on either basis, making it a clean print. Standalone tells a materially different story: parent-only revenue was just ₹15.83 Cr against a wider ₹33.23 Cr loss, since the bulk of commission/broking revenue is booked at subsidiary Turtlemint Insurance Broking (TIB) — readers should treat consolidated, not standalone, as the operating picture.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹342.19 Cr+16.4%—
Expenses₹375.21 Cr+12.5%—
PAT₹-25.83 Cr+31.63%+67.08%
Net margin-7.35%+5.4pp—
EPS₹-1-168%—

No year-ago quarter on record — YoY cells may be blank.

The margin trajectory is the clearer signal than the loss figure itself: consolidated net margin improved to -7.6% from -12.8% in Q1 FY27 and an adjusted -17.6% a year ago, the third consecutive quarter of narrowing losses as a share of revenue. The drivers were operating leverage on employee costs (₹64.23 Cr, down from ₹65.44 Cr in Q1 despite higher revenue) and absence of one-offs, partly offset by rising finance costs (₹2.60 Cr) and impairment losses (₹2.41 Cr) tied to the larger receivables base. EPS of ₹(1.00) improved from ₹(1.47) in Q1 FY27, though the comparison is flattered less than it appears since the post-IPO share base (29.45 Cr shares) is nearly 5.6x the pre-IPO count (5.27 Cr) a year earlier.

₹
40.4971.81103.13134.44165.7662.308-1009-0109-2410-1911-1111-12Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹62.3, down 10.6% over the past month of trading.

₹ Cr
-42.69-25.78-8.888.033.12Q4 FY26rev ₹357 Cr-37.78Q1 FY27rev ₹294 Cr-25.83Q2 FY27rev ₹342 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (1 FY-2027 call)
FY27: Full-year consolidated profitability expected, 40%+ annual profit improvement. Long-term (5y): Service EBITDA 24-25%, adjusted EBITDA margin 18-20%. No specific quarterly or revenue growth guidance given (board decided against formal guidance).

Our pre-result preview had flagged a ₹320-350 Cr revenue range and a 'profitability test' after Q1's loss; the ₹342.19 Cr print lands in-range (inline vs street), but the profitability test is only partially cleared — the company is still loss-making, just less so. A web search for Q2-specific consensus PAT estimates turned up nothing concrete; the only hard brokerage anchors on record are Jefferies' and Motilal Oswal's BUY calls (₹190 and ₹180 targets) built on a 38% FY27-29 revenue CAGR and adjusted EBITDA margin reaching ~10% by FY29 — this quarter's 35.3% YoY revenue growth sits just under that pace. Against management's own FY27 guidance of full-year consolidated profitability and 40%+ annual profit improvement, H1 FY27's consolidated loss of ₹63.61 Cr is 49.2% narrower than H1 FY26's ₹125.14 Cr, a pace broadly consistent with the stated target, but full-year profitability itself remains unconfirmed since H2 must swing from loss to profit. No management press release or MD&A commentary accompanied this filing to cross-check against. Separately, the quarter's ₹660.72 Cr IPO proceeds (listed June 29, 2026) pushed consolidated cash and bank balances to ₹734.4 Cr from ₹125.0 Cr at FY26-end; post quarter-end the company deployed ₹149.5 Cr of this into TIB via a rights issue (Oct 20, 2026), per the IPO's stated use-of-proceeds.

  • W1

    FY27 full-year consolidated profitability guidance: H1 loss stands at ₹63.61 Cr, so H2 must deliver a swing of that magnitude plus profit to meet management's target

  • W2

    ₹149.5 Cr capital infusion into subsidiary TIB (Oct 20, 2026) — watch whether it lifts the broking subsidiary's revenue/margin contribution in Q3

  • W3

    Margin trajectory: consolidated NPM has moved -17.6% (adj.) → -12.8% → -7.6% over three quarters; next print should show whether this pace continues toward brokerage-modeled EBITDA breakeven

Informational and educational content only. Not investment advice.